Undanon, John Ervin A.
HRN: 21-27-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/24/2022
04/30/2022
IV
180
Q6
Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes